Canyon Labs, a Salt Lake City-based provider of analytical and packaging lab testing and consulting for medical devices and pharmaceuticals, has acquired the laboratory and consulting divisions of Iuvo BioScience, an ophthalmic medical device and pharmaceutical clinical research services company based in Rush, New York.
The transaction positions Canyon Labs to deliver comprehensive end-to-end solutions in pharmaceutical and medical device development and strengthens Iuvo BioScience’s focus on transformative ophthalmic clinical development contract research, the companies said. The transition includes the integration of Iuvo’s laboratory and consulting personnel into Canyon Labs’ operations, while Iuvo BioScience retains its clinical research team and leadership structure.
“This acquisition marks a significant milestone in the growth of Canyon Labs’ capacity and capabilities,” said Sarah Ptach, president of Canyon Labs. “By strategically aligning our organizations, we are delivering immediate value to our global client base through faster lead times, expanded capacities, and unparalleled expertise at every step of the process. This integration strengthens our commitment to raising the standard of service in outsourced testing and consulting for the health care industry.”
In addition to its Salt Lake City headquarters, Canyon Labs has locations in San Diego and Rochester, New York. The company is backed by Utah-based MedVenture Health.
A leadership team from Iuvo BioScience will join Canyon Labs, including David Kudla, Donnalee Ventura, Nancy Rakiewicz and Christopher Dietz.
“This transaction marks a defining moment for Iuvo,” said Ben Burton, president and CEO of Iuvo. “This strategic decision reinforces our fundamental mission of accelerating patient access to breakthrough vision care treatments. By sharpening our focus on our ophthalmic clinical contract research business, we’re strengthening our ability to provide the high-touch, science-driven solutions our customers and partners have come to expect from Iuvo.”
